Whitehawk Therapeutics, Inc. (WHWK) Insider Trading & SEC Filings
Last SEC filing
Whitehawk Therapeutics, Inc. (WHWK) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-30. 4 Form 8-K material event filings were reported by WHWK in the last 90 days. InsiderAlpha tracks every WHWK SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. trades under the ticker WHWK. InsiderAlpha tracks 30 primary SEC Form 4 filings from 14 reporting insiders for WHWK since 2024, sourced directly from SEC EDGAR.
| SEC CIK | 0001422142 |
|---|
90-Day SEC Filing Activity
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Latest Form 4 filing | 2026-07-30 |
Recent WHWK Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Anupam Dalal | Director | A - Grant or award | 1.28M | $3.92 | $5.00M | SEC | |
| Caley Castelein | Insider | A - Grant or award | 255.1K | $3.92 | $1000K | SEC | |
| Margaret Dugan | Chief Medical Officer | A - Grant or award | 19.1K | $3.92 | $75K | SEC | |
| Bryan Ball | Chief Technical Operations Officer | A - Grant or award | 51.0K | $3.92 | $200K | SEC | |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | A - Grant or award | 38.3K | $3.92 | $150K | SEC | |
| David James Lennon | CHIEF EXECUTIVE OFFICER | A - Grant or award | 51.0K | $3.92 | $200K | SEC | |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | S - Open-market sale | 141.6K | $4.13 | $585K | SEC | |
| Scott M. Giacobello | CHIEF FINANCIAL OFFICER | S - Open-market sale | 77.0K | $3.86 | $297K | SEC | |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | S - Open-market sale | 92.5K | $3.64 | $337K | SEC | |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | S - Open-market sale | 26.4K | $3.46 | $91K | SEC | |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | S - Open-market sale | 6.6K | $3.43 | $23K | SEC | |
| David James Lennon | CHIEF EXECUTIVE OFFICER | S - Open-market sale | 14.5K | $3.38 | $49K | SEC | |
| Bryan Ball | Chief Technical Operations Officer and SVP, Manufacturing Operations | S - Open-market sale | 50.0K | $3.57 | $178K | SEC | |
| David James Lennon | CHIEF EXECUTIVE OFFICER | S - Open-market sale | 63.9K | $3.40 | $217K | SEC | |
| David James Lennon | CHIEF EXECUTIVE OFFICER | S - Open-market sale | 94.1K | $3.43 | $323K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Whitehawk Therapeutics, Inc. (WHWK). Updated in real time as new filings are submitted to the SEC.
Most-Active WHWK Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Caley Castelein | 3 | $16841.14B |
| Anupam Dalal | 2 | $5.00M |
| Margaret Dugan | 1 | $75K |
| Baiteng Zhao | 1 | - |
| David James Lennon | 1 | $200K |
Recent WHWK Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 8.01, 9.01 [SEC]
- - Item 1.01, 3.02, 7.01, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 2.02, 9.01 · Earnings · neutral [SEC]
Whitehawk Therapeutics issued a press release on March 12, 2026 announcing its financial results for the fiscal year ended December 31, 2025. The filing provides standard annual financial results without explicit beat/miss language or forward guidance changes.
Recent Insider Filings
- - Anupam Dalal (Director)
- - Baiteng Zhao (Insider)
- - Emma Reeve (Insider)
- - Richard E. Maroun (Insider)
- - Mohammad Hirmand (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in WHWK insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
WHWK Insider Trading - FAQ
- What is the latest insider trade for WHWK?
- Whitehawk Therapeutics, Inc. (WHWK) had 14 insider filings in the last 90 days, with the most recent on 2026-07-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying WHWK stock?
- 0 insider purchases of WHWK were filed in the last 90 days.
- How many insiders are selling WHWK stock?
- 0 insider sales of WHWK were filed in the last 90 days.
- Where can I see WHWK SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks WHWK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $WLCO Wilco 63 Corp
- $WLDS Wearable Devices Ltd.
- $WLIIU Willow Lane Acquisition Corp. II
- $WLTH WEALTHFRONT CORP
- $WNDW SolarWindow Technologies, Inc.
- $WNW Meiwu Technology Co Ltd
- $WORX SCWorx Corp.
- $WPAC White Pearl Acquisition Corp.
- $WPRT WESTPORT FUEL SYSTEMS INC.
- $WQEY WISeKey International Corp.
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live WHWK dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.